144 related articles for article (PubMed ID: 29193344)
21. Histone H2A-peptide-hybrided upconversion mesoporous silica nanoparticles for bortezomib/p53 delivery and apoptosis induction.
Rong J; Li P; Ge Y; Chen H; Wu J; Zhang R; Lao J; Lou D; Zhang Y
Colloids Surf B Biointerfaces; 2020 Feb; 186():110674. PubMed ID: 31855686
[TBL] [Abstract][Full Text] [Related]
22. Polyglutamic Acid-Gated Mesoporous Silica Nanoparticles for Enzyme-Controlled Drug Delivery.
Tukappa A; Ultimo A; de la Torre C; Pardo T; Sancenón F; Martínez-Máñez R
Langmuir; 2016 Aug; 32(33):8507-15. PubMed ID: 27468799
[TBL] [Abstract][Full Text] [Related]
23. Cell penetrating peptides as a therapeutic strategy in chronic lymphocytic leukemia.
Arrouss I; Decaudin D; Choquet S; Azar N; Parizot C; Zini JM; Nemati F; Rebollo A
Protein Pept Lett; 2015; 22(6):539-46. PubMed ID: 25687226
[TBL] [Abstract][Full Text] [Related]
24. Functionalized mesoporous silica nanoparticle-based visible light responsive controlled release delivery system.
Knežević NŽ; Trewyn BG; Lin VS
Chem Commun (Camb); 2011 Mar; 47(10):2817-9. PubMed ID: 21240408
[TBL] [Abstract][Full Text] [Related]
25. Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides.
Braun K; Pochert A; Lindén M; Davoudi M; Schmidtchen A; Nordström R; Malmsten M
J Colloid Interface Sci; 2016 Aug; 475():161-170. PubMed ID: 27174622
[TBL] [Abstract][Full Text] [Related]
26. Enzyme-responsive silica mesoporous supports capped with azopyridinium salts for controlled delivery applications.
Mas N; Agostini A; Mondragón L; Bernardos A; Sancenón F; Marcos MD; Martínez-Máñez R; Costero AM; Gil S; Merino-Sanjuán M; Amorós P; Orzáez M; Pérez-Payá E
Chemistry; 2013 Jan; 19(4):1346-56. PubMed ID: 23225567
[TBL] [Abstract][Full Text] [Related]
27. Curcumin loaded mesoporous silica: an effective drug delivery system for cancer treatment.
Kotcherlakota R; Barui AK; Prashar S; Fajardo M; Briones D; Rodríguez-Diéguez A; Patra CR; Gómez-Ruiz S
Biomater Sci; 2016 Mar; 4(3):448-59. PubMed ID: 26674254
[TBL] [Abstract][Full Text] [Related]
28. Thymoquinone loaded mesoporous silica nanoparticles retard cell invasion and enhance in vitro cytotoxicity due to ROS mediated apoptosis in HeLa and MCF-7 cell lines.
Goel S; Mishra P
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109881. PubMed ID: 31499940
[TBL] [Abstract][Full Text] [Related]
29. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
[TBL] [Abstract][Full Text] [Related]
30. In Situ and Timed Extraction of Cellular Peptides from Live HeLa Cells by Photo-Switchable Mesoporous Silica Nanocarriers.
Zhang Y; Peng J; Liu Z; Zou H; Wu R
Anal Chem; 2016 Sep; 88(17):8380-4. PubMed ID: 27503534
[TBL] [Abstract][Full Text] [Related]
31. Enzyme-Controlled Nanodevice for Acetylcholine-Triggered Cargo Delivery Based on Janus Au-Mesoporous Silica Nanoparticles.
Llopis-Lorente A; Díez P; de la Torre C; Sánchez A; Sancenón F; Aznar E; Marcos MD; Martínez-Ruíz P; Martínez-Máñez R; Villalonga R
Chemistry; 2017 Mar; 23(18):4276-4281. PubMed ID: 28220973
[TBL] [Abstract][Full Text] [Related]
32. Peptide-laden mesoporous silica nanoparticles with promoted bioactivity and osteo-differentiation ability for bone tissue engineering.
Luo Z; Deng Y; Zhang R; Wang M; Bai Y; Zhao Q; Lyu Y; Wei J; Wei S
Colloids Surf B Biointerfaces; 2015 Jul; 131():73-82. PubMed ID: 25969416
[TBL] [Abstract][Full Text] [Related]
33. Multifunctional envelope-type mesoporous silica nanoparticles for tumor-triggered targeting drug delivery.
Zhang J; Yuan ZF; Wang Y; Chen WH; Luo GF; Cheng SX; Zhuo RX; Zhang XZ
J Am Chem Soc; 2013 Apr; 135(13):5068-73. PubMed ID: 23464924
[TBL] [Abstract][Full Text] [Related]
34. Combination drug release of smart cyclodextrin-gated mesoporous silica nanovehicles.
Zhou S; Sha H; Ke X; Liu B; Wang X; Du X
Chem Commun (Camb); 2015 Apr; 51(33):7203-6. PubMed ID: 25811958
[TBL] [Abstract][Full Text] [Related]
35. Gated magnetic mesoporous silica nanoparticles for intracellular enzyme-triggered drug delivery.
An N; Lin H; Yang C; Zhang T; Tong R; Chen Y; Qu F
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():292-300. PubMed ID: 27612716
[TBL] [Abstract][Full Text] [Related]
36. On the intracellular release mechanism of hydrophobic cargo and its relation to the biodegradation behavior of mesoporous silica nanocarriers.
von Haartman E; Lindberg D; Prabhakar N; Rosenholm JM
Eur J Pharm Sci; 2016 Dec; 95():17-27. PubMed ID: 27267567
[TBL] [Abstract][Full Text] [Related]
37. Self-Regulated Glucose-Sensitive Neoglycoenzyme-Capped Mesoporous Silica Nanoparticles for Insulin Delivery.
Oroval M; Díez P; Aznar E; Coll C; Marcos MD; Sancenón F; Villalonga R; Martínez-Máñez R
Chemistry; 2017 Jan; 23(6):1353-1360. PubMed ID: 27859880
[TBL] [Abstract][Full Text] [Related]
38. Combined Delivery of Temozolomide and Anti-miR221 PNA Using Mesoporous Silica Nanoparticles Induces Apoptosis in Resistant Glioma Cells.
Bertucci A; Prasetyanto EA; Septiadi D; Manicardi A; Brognara E; Gambari R; Corradini R; De Cola L
Small; 2015 Nov; 11(42):5687-95. PubMed ID: 26395266
[TBL] [Abstract][Full Text] [Related]
39. A new strategy for intracellular delivery of enzyme using mesoporous silica nanoparticles: superoxide dismutase.
Chen YP; Chen CT; Hung Y; Chou CM; Liu TP; Liang MR; Chen CT; Mou CY
J Am Chem Soc; 2013 Jan; 135(4):1516-23. PubMed ID: 23289802
[TBL] [Abstract][Full Text] [Related]
40. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo.
Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
